Indications
To facilitate rapid sequence and routine tracheal intubation, as an adjunct to general anesthesia. Also for muscle relaxation during surgery or mechanical ventilation.
Contraindications
Hypersensitivity (such as anaphylaxis) to rocuronium or to other neuromuscular blocking agents.
Adult dose
Rapid sequence intubation: 0.6-1.2 mg/kg IV, in a patient who is already adequately anesthetized. Good intubating conditions in most patients in under 2 minutes.
Routine intubation: 0.6 mg/kg IV. A lower dose of 0.45 mg/kg may be used.
Obese patients: base the dose on actual body weight.
Maintenance: 0.1, 0.15 or 0.2 mg/kg IV, only once recovery from the last dose is evident.
Pediatric dose
Not recommended for rapid sequence intubation in children.
Routine intubation: 0.6 mg/kg IV. A lower dose of 0.45 mg/kg may be used, depending on the anesthetic and the child's age.
Route
IV
Special considerations
It has no effect on consciousness or pain. A paralyzed patient can still be awake and hurting, so give adequate sedation or anesthesia with it.
Use it only when intubation, ventilation, oxygen and a reversal agent are all immediately available.
It lasts much longer than succinylcholine: about 31 minutes (range 15-85) after 0.6 mg/kg, and about 67 minutes (range 38-160) after 1.2 mg/kg. Expect it to last longer still in the elderly and in liver disease.
When circulation is slow, as in heart disease or old age, onset can be slow too. Do not raise the dose to speed it up. Allow more time.
Severe anaphylaxis has been reported, and cross-reactivity with other paralytics is possible.
Follow your local protocols. Sources: FDA drug labels: Rocuronium bromide. Levels from the National EMS Scope of Practice Model (2019).